Pseudoephedrine sulfate

GPTKB entity

Statements (55)
Predicate Object
gptkbp:instance_of gptkb:chemical_compound
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:Claritin-D_12_Hour
gptkb:Claritin-D
gptkbp:appointed_by oral route
gptkbp:approves gptkb:FDA
gptkbp:contraindication gptkb:sneaker
hypertension
hyperthyroidism
severe coronary artery disease
gptkbp:developed_by ephedrine
https://www.w3.org/2000/01/rdf-schema#label Pseudoephedrine sulfate
gptkbp:ingredients C10 H13 N O4 S
gptkbp:is_analyzed_in clinical trials
pharmacology studies
drug interaction studies
nasal congestion studies
gptkbp:is_associated_with methamphetamine production
gptkbp:is_available_in liquid form
tablet form
extended-release form
gptkbp:is_available_on gptkb:drug
gptkbp:is_known_for decreasing nasal swelling
improving airflow through nasal passages
opening nasal airways
reducing sinus pressure
gptkbp:is_often_depicted_as allergy relief products
cold and flu remedies
sinus relief products
gptkbp:is_part_of combination therapies
decongestant medications
flu medications
hay fever treatments
multi-symptom cold medications
gptkbp:is_subject_to purchase limits
gptkbp:is_used_by gptkb:Person
adults
gptkbp:is_used_for relief of nasal congestion
gptkbp:is_used_in allergy medications
cold medications
sinus medications
gptkbp:material gptkb:drug
vasoconstrictor
gptkbp:metabolism liver
gptkbp:operates_under various brand names
gptkbp:regulates Controlled Substances Act
gptkbp:side_effect dizziness
nausea
insomnia
increased heart rate
gptkbp:suitable_for pregnant women
people with certain medical conditions
nursing mothers
children under 4 years old
gptkbp:type_of 570-68-1